The 5 most recent market catalysts affecting $AMED, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 26, 2026
Corporate Catalyst
Neutral
Impact 60
Autonomix Medical Announces Issuance Of U.S. Patent Titled 'Systems And Methods For Regulating Organ And/Or Tumor Growth Rates, Function, And/Or Development' On August 25
Autonomix Medical announced the issuance of a new U.S. patent, 'Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.' This patent is si…
Aug 24, 2026
Corporate Catalyst
Neutral
Impact 65
Autonomix Medical Will Be Granted U.S. Patent No. 12,714,780 Tomorrow (August 25, 2026), Titled “Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.”
Autonomix Medical is set to receive U.S. Patent No. 12,714,780, titled 'Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.' This pate…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
Autonomix Medical Granted U.S. Patent Titled 'Systems And Methods For Treating Cancer And/Or Augmenting Organ Function'
Autonomix Medical secured a new U.S. patent covering technologies to sense, map, and selectively target nerves associated with tumors, cancer pain, and organ function. This strengt…
Jul 24, 2026
Corporate Catalyst
Bullish
Impact 60
Autonomix Medical Announces Results From Preclinical Study Demonstrating Ability Of Its Neural Sensing Platform To Detect, Localize And Confirm Changes In Renal Neural Activity
Autonomix Medical disclosed successful preclinical study results for its neural sensing platform, which demonstrated the ability to detect, localize, and confirm changes in renal n…
Jul 23, 2026
Corporate Catalyst
Neutral
Impact 60
Autonomix Medical Awarded U.S. Patent For Autonomic Nervous System Assessment Systems, Kits, And Methods
Autonomix Medical announced it has been awarded U.S. Patent No. 12,471,776 for its ANS assessment systems. This patent is significant as it provides intellectual property protectio…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.